The point mutation gamma 2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes
- PMID: 20303942
- PMCID: PMC7615656
- DOI: 10.1016/j.ejphar.2010.03.015
The point mutation gamma 2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes
Abstract
Benzodiazepine site agonists or inverse agonists enhance or reduce gamma-aminobutyric acid(A) (GABA(A)) receptor-mediated inhibition of neurons, respectively. Recently, it was demonstrated that the point mutation gamma 2F77I causes a drastic change in the affinity of a variety of benzodiazepine agonists or inverse agonists in receptor binding studies. Here we investigated the potency and efficacy of 10 benzodiazepine site ligands from 6 structural classes in wild-type and gamma 2F77I point mutated recombinant GABA(A) receptors composed of alpha 1 beta 3 gamma 2, alpha 2 beta 3 gamma 2, alpha 3 beta 3 gamma 2, alpha 4 beta 3 gamma 2, alpha 5 beta 3 gamma 2, and alpha 6 beta 3 gamma 2 subunits. Results indicate that the effects of the benzodiazepine site ligands zolpidem, zopiclone, Cl218872, L-655,708 and DMCM were nearly completely eliminated in all mutated receptors up to a 1 microM concentration. The effects of bretazenil, Ro15-1788 or abecarnil were eliminated in some, but not all mutated receptors, suggesting that the gamma 2F77I mutation differentially influences the actions of these ligands in different receptor subtypes. In addition, this point mutation also influences the efficacy of diazepam for enhancing GABA-induced chloride flux, suggesting that the amino acid residue gamma 2F77 might also be involved in the transduction of the effect of benzodiazepines from binding to gating. The application of these drugs in a novel mouse model is discussed.
(c) 2010 Elsevier B.V. All rights reserved.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7615656/bin/EMS29880-f001.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7615656/bin/EMS29880-f002.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7615656/bin/EMS29880-f003.gif)
![Fig. 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7615656/bin/EMS29880-f004.gif)
![Fig. 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7615656/bin/EMS29880-f005.gif)
Similar articles
-
Role of the histidine residue at position 105 in the human alpha 5 containing GABA(A) receptor on the affinity and efficacy of benzodiazepine site ligands.Br J Pharmacol. 2002 Jan;135(1):248-56. doi: 10.1038/sj.bjp.0704459. Br J Pharmacol. 2002. PMID: 11786501 Free PMC article.
-
Actions of two GABAA receptor benzodiazepine-site ligands that are mediated via non-γ2-dependent modulation.Eur J Pharmacol. 2011 Sep;666(1-3):111-21. doi: 10.1016/j.ejphar.2011.05.011. Epub 2011 May 19. Eur J Pharmacol. 2011. PMID: 21616065
-
Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.Mol Pharmacol. 1996 Nov;50(5):1364-75. Mol Pharmacol. 1996. PMID: 8913369
-
A closer look at the high affinity benzodiazepine binding site on GABAA receptors.Curr Top Med Chem. 2011;11(2):241-6. doi: 10.2174/156802611794863562. Curr Top Med Chem. 2011. PMID: 21189125 Review.
-
Mapping of the benzodiazepine recognition site on GABA(A) receptors.Curr Top Med Chem. 2002 Aug;2(8):833-9. doi: 10.2174/1568026023393444. Curr Top Med Chem. 2002. PMID: 12171574 Review.
Cited by
-
GABAA Receptor Availability in Relation to Cortical Excitability in Depressed and Healthy: A Positron Emission Tomography and Transcranial Magnetic Stimulation Study.Neuropsychobiology. 2024;83(1):17-27. doi: 10.1159/000535512. Epub 2023 Dec 27. Neuropsychobiology. 2024. PMID: 38151012 Free PMC article.
-
The molecular basis of drug selectivity for α5 subunit-containing GABAA receptors.Nat Struct Mol Biol. 2023 Dec;30(12):1936-1946. doi: 10.1038/s41594-023-01133-1. Epub 2023 Oct 30. Nat Struct Mol Biol. 2023. PMID: 37903907 Free PMC article.
-
Search for Novel Therapies for Essential Tremor Based on Positive Modulation of α6-Containing GABAA Receptors.Tremor Other Hyperkinet Mov (N Y). 2023 Oct 23;13:39. doi: 10.5334/tohm.796. eCollection 2023. Tremor Other Hyperkinet Mov (N Y). 2023. PMID: 37900009 Free PMC article.
-
Cryo-EM structures reveal native GABAA receptor assemblies and pharmacology.Nature. 2023 Oct;622(7981):195-201. doi: 10.1038/s41586-023-06556-w. Epub 2023 Sep 20. Nature. 2023. PMID: 37730991 Free PMC article.
-
The Z-Drugs Zolpidem, Zaleplon, and Eszopiclone Have Varying Actions on Human GABA A Receptors Containing γ1, γ2, and γ3 Subunits.Front Neurosci. 2020 Nov 19;14:599812. doi: 10.3389/fnins.2020.599812. eCollection 2020. Front Neurosci. 2020. PMID: 33328871 Free PMC article.
References
-
- Atack JR. Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site. Curr Drug Targets. 2003;2:213–232. - PubMed
-
- Atack JR, Bayley PJ, Seabrook GR, Wafford KA, McKernan RM, Dawson GR. L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors. Neuropharmacology. 2006;51:1023–1029. - PubMed
-
- Atack JR, Maubach KA, Wafford KA, O’Connor D, Rodrigues AD, Evans DC, Tattersall FD, Chambers MS, MacLeod AM, Eng WS, Ryan C, et al. In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylme thoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist. J Pharmacol Exp Ther. 2009;331:470–484. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases